. . . . . . . . . . . . "[Immunostaining for p53 is the only candidate biomarker deemed ready for prime time. This has been recommended for use clinically as an adjunct to histological diagnosis of dysplastic Barrett's esophagus in the 2014 British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2016-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:50:42+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .